Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Miho Hiraki"'
Autor:
Yozo Mitsui, Inik Chang, Shinichiro Fukuhara, Miho Hiraki, Naoko Arichi, Hiroaki Yasumoto, Hiroshi Hirata, Soichiro Yamamura, Varahram Shahryari, Guoren Deng, Darryn K. Wong, Shahana Majid, Hiroaki Shiina, Rajvir Dahiya, Yuichiro Tanaka
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/e4fb318d0e86411e9d13d03418507e7a
Autor:
Yozo Mitsui, Naoko Arichi, Keita Inoue, Miho Hiraki, Shigenobu Nakamura, Takeo Hiraoka, Noriyoshi Ishikawa, Riruke Maruyama, Hiroaki Yasumoto, Hiroaki Shiina
Publikováno v:
Case Reports in Urology, Vol 2014 (2014)
Bladder cancer is the second most common genitourinary malignancy and has variable metastatic potential; however, choroidal and cutaneous metastases are extremely rare. Generally, a patient with these uncommon metastases has a very poor prognosis. We
Externí odkaz:
https://doaj.org/article/cdbc44104fff4409b3134b1de920dcc7
Publikováno v:
European Urology Open Science, Vol 19, Iss, Pp e197-(2020)
Autor:
Rajvir Dahiya, Takeo Hiraoka, Hiroaki Yasumoto, Yozo Mitsui, Miho Hiraki, Hiroaki Shiina, Naoko Arichi, Hiroshi Hirata, Shigenobu Nakamura, Yuichiro Tanaka, Masahiro Sumura
Publikováno v:
Oncoscience
In the current study, we investigated a combination of docetaxel and thalidomide (DT therapy) in castration-resistant prostate cancer (CRPC) patients. We identified marker genes that predict the effect of DT therapy. Using an androgen-insensitive PC3
Publikováno v:
Journal of Urology. 197
Autor:
Nobuhiro Nishimura, Nanae Harashima, Miho Hiraki, Mamoru Harada, Kohji Naora, Hiroaki Shiina, Hiroki Tamaki, Naoko Arichi
Publikováno v:
Oncotarget
// Hiroki Tamaki 1, 2 , Nanae Harashima 1 , Miho Hiraki 3 , Naoko Arichi 3 , Nobuhiro Nishimura 2 , Hiroaki Shiina 3 , Kohji Naora 2 , Mamoru Harada 1 1 Department of Immunology, Shimane University Faculty of Medicine, Shimane, Japan. 2 Department of
Autor:
Asuka Araki, Yuichiro Tanaka, Hiroaki Shiina, Miho Hiraki, Noriyoshi Ishikawa, Naoko Arichi, Hiroaki Yasumoto, Taichi Nagami, Riruke Maruyama, Yozo Mitsui, Rajvir Dahiya
Publikováno v:
Oncotarget
// Yozo Mitsui 1 , Hiroaki Yasumoto 1 , Taichi Nagami 1 , Miho Hiraki 1 , Naoko Arichi 1 , Noriyoshi Ishikawa 2 , Asuka Araki 2 , Riruke Maruyama 2 , Yuichiro Tanaka 3 , Rajvir Dahiya 3 , Hiroaki Shiina 1 1 Departments of Urology, Shimane University
Autor:
Hiroaki Shiina, Riruke Maruyama, Takeo Hiraoka, Miho Hiraki, Naoko Arichi, Noriyoshi Ishikawa, Hiroaki Yasumoto, Shigenobu Nakamura, Keita Inoue, Yozo Mitsui
Publikováno v:
Case Reports in Urology, Vol 2014 (2014)
Case Reports in Urology
Case Reports in Urology
Bladder cancer is the second most common genitourinary malignancy and has variable metastatic potential; however, choroidal and cutaneous metastases are extremely rare. Generally, a patient with these uncommon metastases has a very poor prognosis. We
Autor:
Priyanka Kulkarni, Naoko Arichi, Guoren Deng, Yutaka Hashimoto, Shigekatsu Maekawa, Pritha Dasgupta, Taku Kato, Hiroaki Shiina, Mitsuho Imai-Sumida, Shahana Majid, Miho Hiraki, Rajvir Dahiya, Ryan Kenji Wong, Soichiro Yamamura, Marisa Shiina, Yozo Mitsui, Sharanjot Saini, Koichi Nakajima, Yuichiro Tanaka, Shinichiro Fukuhara
Publikováno v:
Molecular cancer research : MCR. 15(7)
The proteoglycan versican (VCAN) promotes tumor progression and enhances metastasis in several cancers; however, its role in clear cell renal cell carcinoma (ccRCC) remains unknown. Recent evidence suggests that VCAN is an important target of chromos
Autor:
Hiroaki Yasumoto, Miho Hiraki, Rajvir Dahiya, Naoko Arichi, Inik Chang, Shinichiro Fukuhara, Hiroaki Shiina, Yozo Mitsui, Yuichiro Tanaka
Publikováno v:
Journal of Urology. 195